En los lactantes, la ERGE puede causar vómitos y malhumor después de comer. En niños mayores y adolescentes, la ERGE puede generar acidez y malestar en el estómago y el pecho. del Rosario, MD. Fecha de revisión: enero de Artículo anterior | Artículo siguiente · Vol. clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE) Información del artículo. Revisión sobre enfermedad por reflujo gastroesofágico (ERGE) Available in: ?id= · How to cite · Complete.

Author: Meztirg Faekree
Country: Martinique
Language: English (Spanish)
Genre: History
Published (Last): 2 March 2018
Pages: 272
PDF File Size: 9.31 Mb
ePub File Size: 11.50 Mb
ISBN: 804-9-66443-907-3
Downloads: 27903
Price: Free* [*Free Regsitration Required]
Uploader: Akinoran

Empiric therapy for gastroesophageal reflux disease. Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Risk of community-acquired pneumonia in veteran patients to whom adticulo pump inhibitors were dispensed.

Revisión sobre enfermedad por reflujo gastroesofágico – Artículos – IntraMed

Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: Efficacy and cost effectiveness of lansoprazole versus omeprazole in maintenance treatment of symptomatic gastroeso-phageal reflux disease.


Am J Gastroenterol, 95pp. The usefulness of a structured questionnaire in the assesment of symptomatic gastroesophageal reflux disease. Ineffective motility is not a marker for gastroesophageal reflux disease. Esomeprazole 20 mg maintains symptoms articull in endoscopy-negative gastroesophageal reflux disease: The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

Short-term treatment with proton articul inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Pathogenesis, diagnosis, and therapy. N Engl J Med ; The pathogenesis of heartburn in nonerosive reflux disease: Aliment Pharmacol Ther, 14pp.

reivsion Clin Gastroenterol and Hepatol ; Effective maintenance treatment of reflux eso-phagitis with low-dose lansoprazole. High -versus standarddose ranitidine for control of heartburn in poorly responsive acid reflux disease: The diagnosis and management of gastroesophageal reflux disease. Rao AS, Camilleri M. Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Enfermedad por reflujo gastroesofágico (ERGE) (para Padres)

Acid neutralizing capacity of human saliva. Epidemiology and natural history of gastro-oesophageal reflux disease. An evaluation of increasing doses of ranitidine for treatment of heartburn.


Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro- oesophageal reflux disease. Surg Endosc ; An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Adverse effects of long-term proton pump inhibitor therapy. Adverse effects of proton pump inhibitors.

Scand J Gastroenterol, 33pp. West J Med,pp.

Pantoprazole versus omeprazole in the treatment of reflux esophagitis. N Engl J Med,pp.

One-week omeprazole treatment in the diagnosis of gastrooesophageal reflux disease. Comparison of laparoscopic and open Nissen fundoplication 2 years after operation.

There was a problem providing the content you requested

Am J Med,pp. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. J Fam Pract, 50pp.